Our Blog Melanoma360

Featured image for “President’s Letter | January 2022”
01/27/2022

President’s Letter | January 2022

From the Desk of Samantha Guild   Happy 2022! I hope this year is joyful and healthy for you and…
Blog - Melanoma360
President's Letter
Featured image for “In Plain English: The Results of DreamSeq”
01/27/2022

In Plain English: The Results of DreamSeq

By Kim Margolin, M.D., FACP, FASCO Patients with advanced melanoma—spread to other organs or grown too large in the lymph…
Blog - Melanoma360
In Plain English
Featured image for “One Survivor Finds Empowerment through Education and Supporting Others”
01/26/2022

One Survivor Finds Empowerment through Education and Supporting Others

By Mara Klecker Ann Marie received her first-ever physical in 2019 at the age of 53. She’d lost her father…
Blog - Melanoma360
Survivor Stories
Featured image for “Become a Member of the Supporters Guild”
01/26/2022

Become a Member of the Supporters Guild

“How Can I Help?” Fortunately for AIM, so many of you call or write us and ask this question. And…
Blog - Melanoma360
Philanthropy
Featured image for “FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma”
01/26/2022

FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma

January 26, 2022 (Richmond, California) Earlier today, Immunocore announced that the U.S. Food and Drug Administration (FDA) has approved KIMMTRAK…
Blog - Melanoma360
Breaking News
Featured image for “Walking to Conquer Melanoma: Mike’s Miracle Workers”
01/26/2022

Walking to Conquer Melanoma: Mike’s Miracle Workers

By Mara Klecker Even when the pandemic forced the KDB Melanoma 5k Walk/Run to go virtual in 2020, Mike’s Miracle…
Blog - Melanoma360
Friends, Family, & Caregivers
Philanthropy
Featured image for “International Advocate Spotlight: Australia’s Tamara Dawson”
01/26/2022

International Advocate Spotlight: Australia’s Tamara Dawson

By Mara Klecker Two-thirds of Australians will be diagnosed with a type of skin cancer by the time they are…
Blog - Melanoma360
International Advocate Stories
Survivor Stories
Featured image for “The Role of Social Media in Patient Care”
01/11/2022

The Role of Social Media in Patient Care

Social media has the potential to provide both benefits and harm to cancer patients who turn there looking for information…
Blog - Melanoma360
Podcast
Featured image for “A Heartfelt Thank You To Our Auction Sponsors”
12/09/2021

A Heartfelt Thank You To Our Auction Sponsors

  Thank you, thank you, thank you to the donors for our 2021 online auction! The Gratitude Gala—AIM at Melanoma’s…
Blog - Melanoma360
Philanthropy
Featured image for “President’s Letter | December 2021”
12/09/2021

President’s Letter | December 2021

From the Desk of Samantha Guild Here at AIM at Melanoma, we started 2021 talking about Hope and are ending…
Blog - Melanoma360
President's Letter
01/27/2022

President’s Letter | January 2022

From the Desk of Samantha Guild   Happy 2022! I hope this year is joyful and healthy for you and…
Featured image for “President’s Letter | January 2022”
Blog - Melanoma360
 | 
President's Letter
01/27/2022

In Plain English: The Results of DreamSeq

By Kim Margolin, M.D., FACP, FASCO Patients with advanced melanoma—spread to other organs or grown too large in the lymph…
Featured image for “In Plain English: The Results of DreamSeq”
Blog - Melanoma360
 | 
In Plain English
01/26/2022

One Survivor Finds Empowerment through Education and Supporting Others

By Mara Klecker Ann Marie received her first-ever physical in 2019 at the age of 53. She’d lost her father…
Featured image for “One Survivor Finds Empowerment through Education and Supporting Others”
Blog - Melanoma360
 | 
Survivor Stories
01/26/2022

Become a Member of the Supporters Guild

“How Can I Help?” Fortunately for AIM, so many of you call or write us and ask this question. And…
Featured image for “Become a Member of the Supporters Guild”
Blog - Melanoma360
 | 
Philanthropy
01/26/2022

FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma

January 26, 2022 (Richmond, California) Earlier today, Immunocore announced that the U.S. Food and Drug Administration (FDA) has approved KIMMTRAK…
Featured image for “FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma”
Blog - Melanoma360
 | 
Breaking News
01/26/2022

Walking to Conquer Melanoma: Mike’s Miracle Workers

By Mara Klecker Even when the pandemic forced the KDB Melanoma 5k Walk/Run to go virtual in 2020, Mike’s Miracle…
Featured image for “Walking to Conquer Melanoma: Mike’s Miracle Workers”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy
01/26/2022

International Advocate Spotlight: Australia’s Tamara Dawson

By Mara Klecker Two-thirds of Australians will be diagnosed with a type of skin cancer by the time they are…
Featured image for “International Advocate Spotlight: Australia’s Tamara Dawson”
Blog - Melanoma360
 | 
International Advocate Stories
 | 
Survivor Stories
01/11/2022

The Role of Social Media in Patient Care

Social media has the potential to provide both benefits and harm to cancer patients who turn there looking for information…
Featured image for “The Role of Social Media in Patient Care”
Blog - Melanoma360
 | 
Podcast
12/09/2021

A Heartfelt Thank You To Our Auction Sponsors

  Thank you, thank you, thank you to the donors for our 2021 online auction! The Gratitude Gala—AIM at Melanoma’s…
Featured image for “A Heartfelt Thank You To Our Auction Sponsors”
Blog - Melanoma360
 | 
Philanthropy
12/09/2021

President’s Letter | December 2021

From the Desk of Samantha Guild Here at AIM at Melanoma, we started 2021 talking about Hope and are ending…
Featured image for “President’s Letter | December 2021”
Blog - Melanoma360
 | 
President's Letter